ELLIPTIC LABORATORIES ASA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.24 NOK | +1.75% |
|
+8.85% | -4.69% |
| Apr. 25 | Elliptic Labs Shipping on vivo iQOO Z9 and Z9 Turbo Smartphones | CI |
| Apr. 24 | Elliptic Labs Shipping Its AI Software Platform on Lenovo's Newest ThinkPad P Series Workstation Laptops | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,208 | 2,882 | 2,295 | 1,673 | 1,673 | - |
| Enterprise Value (EV) 1 | 1,208 | 2,681 | 2,129 | 1,697 | 1,643 | 1,625 |
| P/E ratio | -9 x | -252 x | -71.1 x | -47.3 x | 48.4 x | 12.3 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 27 x | 45.7 x | 44.1 x | 26.1 x | 8.07 x | 4.03 x |
| EV / Revenue | 27 x | 42.5 x | 40.9 x | 24.8 x | 7.92 x | 3.92 x |
| EV / EBITDA | - | -948 x | -69.1 x | -50.6 x | 23.9 x | 7.43 x |
| EV / FCF | - | -94,277,852 x | -59,008,572 x | - | - | - |
| FCF Yield | - | -0% | -0% | - | - | - |
| Price to Book | - | 8.41 x | 7.04 x | 5.82 x | 4.87 x | 3.39 x |
| Nbr of stocks (in thousands) | 95,846 | 103,842 | 104,074 | 104,838 | 104,838 | - |
| Reference price 2 | 12.60 | 27.75 | 22.05 | 15.96 | 15.96 | 15.96 |
| Announcement Date | 4/21/21 | 3/10/22 | 2/17/23 | 2/15/24 | - | - |
1NOK in Million2NOK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 44.73 | 63.04 | 52.06 | 68.32 | 207.5 | 414.9 |
| EBITDA 1 | - | -2.829 | -30.81 | -33.52 | 68.78 | 218.7 |
| EBIT 1 | - | -11.14 | -42.13 | -49.74 | 50.04 | 192.9 |
| Operating Margin | - | -17.67% | -80.92% | -72.81% | 24.12% | 46.48% |
| Earnings before Tax (EBT) 1 | - | -13.09 | -39.3 | -46.86 | 48.51 | 191.3 |
| Net income 1 | - | -11.16 | -32.04 | -37.85 | 37.91 | 149.2 |
| Net margin | - | -17.7% | -61.54% | -55.4% | 18.27% | 35.97% |
| EPS 2 | -1.400 | -0.1100 | -0.3100 | -0.3600 | 0.3300 | 1.300 |
| Free Cash Flow | - | -28.43 | -36.08 | - | - | - |
| FCF margin | - | -45.11% | -69.31% | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 4/21/21 | 3/10/22 | 2/17/23 | 2/15/24 | - | - |
1NOK in Million2NOK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | 201 | 166 | 89.7 | 30.5 | 48.6 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | -28.4 | -36.1 | - | - | - |
| ROE (net income / shareholders' equity) | - | -4.2% | -9.7% | -12% | 11.7% | 36% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 3.300 | 3.130 | 2.930 | 3.280 | 4.710 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 17.6 | 23.3 | 25.5 | 34.6 | 40.8 |
| Capex / Sales | - | 27.94% | 44.81% | 37.29% | 16.69% | 9.84% |
| Announcement Date | 4/21/21 | 3/10/22 | 2/17/23 | 2/15/24 | - | - |
1NOK in Million2NOK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15.96
NOK
Average target price
25
NOK
Spread / Average Target
+56.64%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.69% | 152M | |
| -20.09% | 26.53B | |
| +1.38% | 9.32B | |
| -6.43% | 4.6B | |
| -25.68% | 729M | |
| -1.92% | 479M | |
| -9.71% | 448M | |
| -28.88% | 210M | |
| -42.63% | 189M | |
| -38.99% | 149M |
- Stock Market
- Equities
- ELABS Stock
- Financials Elliptic Laboratories ASA
